AAAAAA

   
Results: 1-16 |
Results: 16

Authors: SHIMADA T YAMAZAKI H FOROOZESH M HOPKINS NE ALWORTH WL GUENGERICH FP
Citation: T. Shimada et al., SELECTIVITY OF POLYCYCLIC INHIBITORS FOR HUMAN CYTOCHROME P450S 1A1, 1A2, AND 1B1, Chemical research in toxicology, 11(9), 1998, pp. 1048-1056

Authors: KOBAYASHI Y STROBEL SM HOPKINS NE ALWORTH WL HALPERT JR
Citation: Y. Kobayashi et al., CATALYTIC PROPERTIES OF AN EXPRESSED CYTOCHROME-P450 2B1 FROM A WISTAR-KYOTO RAT-LIVER CDNA LIBRARY, Drug metabolism and disposition, 26(10), 1998, pp. 1026-1030

Authors: HOPKINS NE ENGLISH N HUGHES V ROWLEY CW WOLF CR ALWORTH WL
Citation: Ne. Hopkins et al., INDUCTION OF CYP102 (CYTOCHROME-P450(BM-3)) IN BACILLUS-MEGATERIUM BY17-BETA-ESTRADIOL AND 4-SEC-BUTYLPHENOL (VOL 244, PG 868, 1998), Biochemical and biophysical research communications, 246(3), 1998, pp. 933-934

Authors: HOPKINS NE ENGLISH N HUGHES V ROWLEY CW WOLF CR ALWORTH WL
Citation: Ne. Hopkins et al., INDUCTION OF CYP102 (CYTOCHROME P450(BM-3)) IN BACILLUS-MEGATERIUM BY17-BETA-ESTRADIOL AND 4-SEC-BUTYLPHENOL, Biochemical and biophysical research communications, 244(3), 1998, pp. 868-872

Authors: MAGUE JT FOROOZESH M HOPKINS NE GAN LLS ALWORTH WL
Citation: Jt. Mague et al., ARYL ACETYLENE INHIBITORS FOR CYTOCHROME P450-BASED MONOOXYGENASE ISOZYMES, Journal of chemical crystallography, 27(3), 1997, pp. 183-189

Authors: HOPKINS NE ROWLEY CW ALWORTH WL
Citation: Ne. Hopkins et al., EFFECTS OF PHYTOCHEMICALS ON THE INDUCTION OF CYP102 BY 4-SEC-BUTYLPHENOL AND 17-BETA ESTRADIOL, The FASEB journal, 11(9), 1997, pp. 276-276

Authors: ROBERTS ES HOPKINS NE FOROOZESH M ALWORTH WL HALPERT JR HOLLENBERG PF
Citation: Es. Roberts et al., INACTIVATION OF CYTOCHROME P450S 2B1, 2B4, 2B6, AND 2B11 BY ARYLALKYNES, Drug metabolism and disposition, 25(11), 1997, pp. 1242-1248

Authors: DREISBACH AW FERENCZ N HOPKINS NE FUENTES MG REGE AB GEORGE WJ LERTORA JJL
Citation: Aw. Dreisbach et al., URINARY-EXCRETION OF 6-HYDROXYCHLORZOXAZONE AS AN INDEX OF CYP2E1 ACTIVITY, Clinical pharmacology and therapeutics, 58(5), 1995, pp. 498-505

Authors: DREISBACH AW FERENCZ N HOPKINS NE FUENTES MG REGE AB GEORGE WJ LERTORA JJL
Citation: Aw. Dreisbach et al., URINARY-EXCRETION OF 6-OH-CHLORZOXAZONE (CXZ-OH) IS FORMATION RATE LIMITED, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 217-217

Authors: ROBERTS ES HOPKINS NE ZALUZEC EJ GAGE DA ALWORTH WL HOLLENBERG PF
Citation: Es. Roberts et al., MECHANISM-BASED INACTIVATION OF CYTOCHROME-P450 2B1 BY 9-ETHYNYLPHENANTHRENE, Archives of biochemistry and biophysics, 323(2), 1995, pp. 295-302

Authors: ROBERTS ES BALLOU DP HOPKINS NE ALWORTH WL HOLLENBERG PF
Citation: Es. Roberts et al., MECHANISTIC STUDIES OF 9-ETHYNYLPHENANTHRENE-INACTIVATED CYTOCHROME-P450 2B1, Archives of biochemistry and biophysics, 323(2), 1995, pp. 303-312

Authors: ROBERTS ES HOPKINS NE ZALUZEC EJ ALWORTH WL GAGE DA HOLLENBERG PF
Citation: Es. Roberts et al., MECHANISM-BASED INACTIVATION OF CYTOCHROME-P450 2B1 BY 9-ETHYNYLNAPTHALENE, The FASEB journal, 8(7), 1994, pp. 10001245-10001245

Authors: DREISBACH AW FERENCZ N HOPKINS NE REGE AB GEORGE WJ LERTORA JJL
Citation: Aw. Dreisbach et al., URINARY-EXCRETION OF 6-OH-CHLORZOXAZONE (CXZ-OH) AS AN INDEX OF CYTOCHROME P4502E1 ACTIVITY, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 140-140

Authors: ROBERTS ES HOPKINS NE ZALUZEC EJ GAGE DA ALWORTH WL HOLLENBERG PF
Citation: Es. Roberts et al., IDENTIFICATION OF ACTIVE-SITE PEPTIDES FROM H-3 LABELED 2-ETHYNYLNAPHTHALENE-INACTIVATED P450 2B1 AND 2B4 USING AMINO-ACID SEQUENCING AND MASS-SPECTROMETRY, Biochemistry, 33(12), 1994, pp. 3766-3771

Authors: ROBERTS ES HOPKINS NE ALWORTH WL HOLLENBERG PF
Citation: Es. Roberts et al., MECHANISM-BASED INACTIVATION OF CYTOCHROME-P450 2B1 BY 2-ETHYNYLNAPHTHALENE - IDENTIFICATION OF AN ACTIVE-SITE PEPTIDE, Chemical research in toxicology, 6(4), 1993, pp. 470-479

Authors: DREISBACH AW FERENCZ N HOPKINS NE REGE AB GEORGE WJ LERTORA JJL
Citation: Aw. Dreisbach et al., HYDROXYLATION INDEX FOR CHLORZOXAZONE AS A MEASURE OF CYTOCHROME-P4502E1 ACTIVITY, Clinical research, 41(4), 1993, pp. 10000758-10000758
Risultati: 1-16 |